CAJ | 학술논문

血管黏附蛋白(VAP)与众多疾病的发生相关，是众多疾病治疗的靶点。本文通过运用CNABS，DWPI，Sipoabs数据库进行检索和分析，统计涉及VAP-1的专利申请，从专利的年申请量、申请人、技术领域、涉及的疾病治疗领域进行分析，供相关药物研发企业参考，统计结果显示目前涉及VAP-1的全球专利申请数量偏少，申请主要来源于欧美日等西方国家，涉及VAP-1的药物研发公司还没有完成相关专利的布局，这在一定程度上为我国申请人在相关领域的研发提供了机遇。
혈관점부단백(VAP)여음다질병적발생상관，시음다질병치료적파점。본문통과운용CNABS，DWPI，Sipoabs수거고진행검색화분석，통계섭급VAP-1적전리신청，종전리적년신청량、신청인、기술영역、섭급적질병치료영역진행분석，공상관약물연발기업삼고，통계결과현시목전섭급VAP-1적전구전리신청수량편소，신청주요래원우구미일등서방국가，섭급VAP-1적약물연발공사환몰유완성상관전리적포국，저재일정정도상위아국신청인재상관영역적연발제공료궤우。
Vascular adhesion protein-1 (VAP-1) is related to the occurrence of numerous diseases and is target of many diseases.The information on annual application amount,applicant,technology and treatment field was analyzed by combinational utilization of CNABS,DWPI and Sipoabs databases,to provide research and development suggestions for related pharmaceutical companies.The results show that the number of global patent applications related to VAP-1 is quite small.The applications mainly come from western countries such as Europe,America and Japan.Companies in-volved in VAP-1 has not completed the layout of the relevant patents,which might provide an opportunity for Chinese applicants of in this relevant field.